It’s crazy that mainstream media still only talks about Ozempic and Mounjaro, barely mentioning Retatrutide.
In Phase 2 trials, Retatrutide has shown 24.2% weight loss over 48 weeks — better than Mounjaro in many cases. But because it’s still in the clinical stage, the big outlets aren’t hyping it yet.
If Retatrutide got the same attention as Ozempic, it would probably dominate the market overnight. Maybe that’s why there’s a delay — there’s too much money tied up in pushing the existing drugs first.
For anyone curious, it is already possible to buy Retatrutide online for research purposes
. BuyOnlineMedication.com
has German lab tested pens shipped safely in the UK with refrigerated packaging.
Feels like we’re seeing pharma politics in action.
